Abstract
The lack of an official-stage classification system for thymic malignancies is an issue that hampers progress in this rare disease. A collaborative effort by the International Association for the Study of Lung Cancer and the International Thymic Malignancies Interest Group is underway to develop proposals for such a system. A database of more than 10,000 cases worldwide has been assembled to provide a solid basis for analysis. This report outlines the structure of the effort and the process that has been designed.
| Original language | English |
|---|---|
| Pages (from-to) | 1467-1473 |
| Number of pages | 7 |
| Journal | Journal of Thoracic Oncology |
| Volume | 8 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - 2013 |
| Externally published | Yes |
Keywords
- Staging of stage classification
- Thymic carcinoma
- Thymoma
ASJC Scopus subject areas
- Oncology
- Pulmonary and Respiratory Medicine
Access to Document
Other files and links
Fingerprint
Dive into the research topics of 'The IASLC/ITMIG Thymic Malignancies Staging Project Development of a Stage Classification for Thymic Malignancies'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
The IASLC/ITMIG Thymic Malignancies Staging Project Development of a Stage Classification for Thymic Malignancies. / Detterbeck, Frank C.; Asamura, Hisao; Crowley, John et al.
In: Journal of Thoracic Oncology, Vol. 8, No. 12, 2013, p. 1467-1473.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - The IASLC/ITMIG Thymic Malignancies Staging Project Development of a Stage Classification for Thymic Malignancies
AU - Detterbeck, Frank C.
AU - Asamura, Hisao
AU - Crowley, John
AU - Falkson, Conrad
AU - Giaccone, Giuseppe
AU - Giroux, Dori
AU - Huang, James
AU - Kim, Jhingook
AU - Kondo, Kazuya
AU - Lucchi, Marco
AU - Marino, Mirella
AU - Marom, Edith M.
AU - Nicholson, Andrew
AU - Okumura, Meinoshin
AU - Ruffni, Enrico
AU - Van Schil, Paul
AU - Stratton, Kelly
N1 - Funding Information: S. Call Caja, Hospital Universitari Mutua Terrassa, Terrassa, Spain; U. Ahmad and F. Detterbeck, Yale Cancer Center, New Haven, CT; N. Girard, Louis Pradel Hospital, Lyon, France; Seok Jin Haam, Gangnam Severance Hospital, Seoul, Korea; Mi Kyung Bae, Severance Hospital, Seoul, Korea; D.R. Gomez and E. Marom, MD Anderson Cancer Center, Houston, TX; P. van Schil, Antwerp University Hospital, Antwerp, Belgium; P. Ströbel, University Medical Center Göttingen, Göttingen, Germany; A. Marx, University Medical Center Mannheim, Mannheim, Germany; S. Saita, Azienda Ospedaliero-Universitaria Policlinico V.Emanuele, Catania, Italy; H. Wakelee, Stanford University, Stanford, CA; L. Bertolaccini, Thoracic Surgery, Azienda Ospedaliera S.Croce e Carle, Cuneo, Italy; E. Vallieres, Swedish Cancer Institute, Seattle, WA; W. Scott and S. Su, Fox Chase Cancer Center, Philadelphia, PA; B. Park and J. Marks, Hackensack University Medical Center, Hackensack, NJ; S. Khella, Penn Presbyterian Medical Center, Philadelphia, PA; R. Shen, Mayo Clinic Rochester, Rochester, MN; M. Rosenberg, Alexander Fleming Institute, Buenos Aires, Argentina; M. Rosenberg, Maria Ferrer Institute, Buenos Aires, Argentina; V. Tomulescu, Fundeni Clinical Institute, Bucharest, Romania; J. Huang, Memorial Sloan-Kettering Cancer Center, New York, NY; C. Foroulis, AHEPA University Hospital, Aristotle University Medical School, Thessaloniki, Greece; L. Lang-Lazdunski and Andrea Billè, Guy’s & St. Thomas’ Hospital, London, United Kingdom; J.G. Maessen and M. Keijzers, Maastricht University Medical Centre, Maastricht, Netherlands; H. van Veer, University Hospitals Leuven, Leuven, Belgium; C. Wright, Massachusetts General Hospital, Boston, MA; M. Marino, Regina Elena National Cancer Institute, Rome, Italy; G. Palmieri and C. Buonerba, Università Degli Studi di Napoli Federico II, Napoli, Italy; M. Ferguson, University of Chicago, Chicago, IL; G. Marulli, University of Padua, Padua, Italy; M. Lucchi, University of Pisa, Pisa, Italy; P. Loehrer, Indiana University Simon Cancer Center, Indianapolis, IN; M. Kalkat, Birmingham Heartlands Hospital, Birmingham, United Kingdom; K. Rohrberg and G. Daugaard, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark; A. Toker and S. Erus, Istanbul Medical University, Istanbul, Turkey; M. Kimmich, Klinik Schillerhoehe, Gerlingen, Germany; A. Brunelli and M. Refai, Ospedali Riuniti, Ancona, Italy; A. Nicholson and E. Lim, Royal Brompton Hospital/Harefield NHS Foundation Trust, London, United Kingdom; In Kyu Park, Seoul National Hospital, Seoul, Korea; J. Wagner and B. Tieu, Oregon Health and Science University, Portland, Oregon; Wentao Fang and Jie Zhang, Shanghai Chest Hospital, Jiaotong University Medical School, Shanghai, China; Zhentao Yu, Tianjin Medical University Cancer Hospital, Tianjin, China; Yongtao Han, Sichuan Cancer Hospital, Chengdu, China; Yin Li, Henan Cancer Hospital, Zhengzhou, China; Keneng Chen, Beijing University Cancer Hospital, Beijing, China; Gang Chen, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China; Meinoshin Okumura, Osaka University, Osaka, Japan; Yoshitaka Fujii, Nagoya City University, Aichi, Japan; Hisao Asamura, National Cancer Center Hospital, Tokyo, Japan; Kanji Nagai, National Cancer Center Hospital East, Chiba, Japan; Jun Nakajima, University of Tokyo, Tokyo, Japan; Norihiko Ikeda, Tokyo Medical University, Tokyo, Japan; Shuji Haraguchi, Nippon Medical School, Tokyo, Japan; Takamasa Onuki, Tokyo Women’s Medical University, Tokyo, Japan; Kenji Suzuki, Juntendo University, Tokyo, Japan; Ichiro Yoshino, Chiba University, Chiba, Japan; Masanori Tsuchida, Niigata University, Niigata, Japan; Shoji Takahashi, Shizuoka Cancer Center, Shizuoka, Japan; Kohei Yokoi, Nagoya University, Aichi, Japan; Masayuki Hanyuda, Aichi Medical University, Aichi, Japan; Hiroshi Niwa, Seirei Mikatahara General Hospital, Shizuoka, Japan; Hiroshi Date, Kyoto University, Kyoto, Japan; Yoshimasa Maniwa, Kobe University, Hyogo, Japan; Shinichiro Miyoshi, Okayama University, Okayama, Japan; Kazuya Kondo, Tokushima University, Tokushima, Japan; Akinori Iwasaki, Fukuoka University, Fukuoka, Japan; Tatsuro Okamoto, Kyusyu University, Fukuoka, Japan; Takeshi Nagayasu, Nagasaki University, Nagasaki, Japan; Fumihiro Tanaka, University of Occupational and Environmental Health, Fukuoka, Japan; Minoru Suzuki, Kumamoto University, Kumamoto, Japan; Kazuo Yoshida, Shinshu University, Nagano, Japan; Yusuke Okuma and Hirotoshi Horio, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan; Akihide Matsumura, Kinki-Chuo Chest Medical Center, Osaka, Japan; Masahiko Higashiyama, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; Hiroshi Suehisa, Shikoku Cancer Center, Ehime, Japan; Takuya Onuki, Tsuchiura Kyodo Hospital, Ibaragi, Japan; Yoshifumi Sano, Ehime University, Ehime, Japan; Keishi Kondo, Hokkaido Cancer Center, Hokkaido, Japan; K. Al Kattan, King Khalid University Hospital, Riyadh, Saudi Arabia; R. Cerfolio, University of Alabama, Birmingham, AL; C. Gebitekin, Uludag University School of Medicine, Bursa, Turkey; D. Gomez de Antonio, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain; K.H. Kernstine, University of Texas, Southwestern Medical Center and School of Medicine (SW), Dallas; N. Altorki, The New York Hospital, Cornell Medical Centre, New York, NY; N. Novoa, Salamanca University Hospital, Salamanca, Spain; E. Ruffini and P.L. Filosso, University of Torino, Torino, Italy; S. Saita, University of Catania, Catania, Italy; M. Scarci, Papworth Hospital NHS Foundation Trust, Papworth Everard, Cambridge, United Kingdom; L. Voltolini, Università di Siena, Siena, Italy; W. Weder, University Hospital, Zurich, Switzerland; Wojciech Zurek, Medical University of Gdansk, Gdansk, Poland; A. Arame, Hopital Europeen Georges-Pompidou and Hopital Laennec, Paris, France; C. Casadio, Chirurgia Toracica, Novara, Italy; P. Carbognani, Università di Parma, Parma, Italy; G. Donati, Ospedale di Aosta, Aosta, Italy; S. Keshavjee, University of Toronto, Toronto, Canada; W. Klepetko and B. Moser, Medical University of Vienna, Vienna, Austria; C. Lequaglie, Thoracic Surgery, Rionero in Vulture, Italy; Moishe Liberman, Centre Hospitalier de l’Université de Montréal, Montréal, Canada; M. Mancuso, Ospedale Alessandria, Alessandria, Italy; M. Nosotti, Policlinico, Milan, Italy; L. Spaggiari, Istituto Europeo di Oncologia (IEO), Milan, Italy; P.A. Thomas, Hôpital Nord, Université de la Méditerranée, Marseille, France; E. Rendina, University La Sapienza, Ospedale Sant’ Andrea, Rome, Italy; F. Venuta and M. Anile, Policlinico Umberto I, Rome, Italy; J. Schützner, Teaching Hospital Motol, Prague, Czech Republic; and G. Rocco, Pascale Institute, Napoli, Italy. Funding Information: Peter Goldstraw, Past Chair, Royal Brompton Hospital and Imperial College, London, United Kingdom; Ramón Rami-Porta, Chair, Hospital Universitari Mutua Terrassa, Terrassa, Spain; Hisao Asamura, Chair Elect, National Cancer Center, Tokyo, Japan; David Ball, Peter MacCallum Cancer Institute, Melbourne, Australia; David Beer, University of Michigan, Ann Arbor, MI; Ricardo Beyruti, University of Sao Paulo, Sao Paulo, Brazil; Vanessa Bolejack, Cancer Research And Biostatistics, Seattle, WA; Kari Chansky, Cancer Research And Biostatistics, Seattle, WA; John Crowley, Cancer Research And Biostatistics, Seattle, WA; Frank Detterbeck, Yale University, New Haven, CT; Wilfried Eberhardt, University of Essen, Essen, Germany; John Edwards, Northern General Hospital, Sheffield, United Kingdom; Françoise Galateau-Sallé, Centre Hospitalier Universitaire, Caen, France; Dorothy Giroux, Cancer Research And Biostatistics, Seattle, WA; Fergus Gleeson, Churchill Hospital, Oxford, United Kingdom; Patti Groome, Queen’s Cancer Research Institute, Kingston, Ontario, Canada; James Huang, Memorial Sloan-Kettering Cancer Center, New York, NY; Catherine Kennedy, University of Sydney, Sydney, Australia; Jhingook Kim, Samsung Medical Center, Seoul, Korea; Y. T. Kim, Seoul National University, Seoul, South Korea; Laura Kingsbury, Cancer Research And Biostatistics, Seattle, WA; Haruhiko Kondo, Kyorin University Hospital, Tokyo, Japan; Mark Krasnik, Gentofte Hospital, Copenhagen, Denmark; Kaoru Kubota, Nippon Medical School Hospital, Tokyo, Japan; Antoon Lerut, University Hospitals, Leuven, Belgium; Gustavo Lyons, British Hospital, Buenos Aires, Argentina; Mirella Marino, Regina Elena National Cancer Institute, Rome, Italy; Edith Marom, MD Anderson Cancer Center, Houston, TX; Jan van Meerbeeck, University Hospital, Ghent, Belgium; Alan Mitchell, Cancer Research And Biostatistics, Seattle, WA; Takashi Nakano, Hyogo College of Medicine, Hyogo, Japan; Jennifer Newman, Cancer Research And Biostatistics, Seattle, WA; Andrew Nicholson, Royal Brompton Hospital, London, United Kingdom; Anna Nowak, University of Western Australia, Subiaco, Australia; Michael Peake, Glenfield Hospital, Leicester, United Kingdom; Thomas Rice, Cleveland Clinic, Cleveland, OH; Kenneth Rosenzweig, Mount Sinai Hospital, New York, NY; Enrico Ruffini, University of Torino, Torino, Italy; Valerie Rusch, Memorial Sloan-Kettering Cancer Center, New York, NY; Paul van Schil, University Hospital of Antwerp, Aartselaar, Belgium; Jean-Paul Sculier, Institut Jules Bordet, Brussels, Belgium; Kelly Stratton, Cancer Research And Biostatistics, Seattle, WA; Kenji Suzuki, Juntendo University, Tokyo, Japan; Yuji Tachimori, National Cancer Center, Tokyo, Japan; Charles F. Thomas Jr, Mayo Clinic, Rochester, MN; William Travis, Memorial Sloan-Kettering Cancer Center, New York, NY; Ming Tsao, The Princess Margaret Hospital, Toronto, Ontario, Canada; Andrew Turrisi, Sinai-Grace Hospital, Detroit, MI; Johan Vansteenkiste, University Hospitals, Leuven, Belgium; Hirokazu Watanabe, National Cancer Center Hospital, Tokyo, Japan; Yi-Iong Wu, Guangdong General Hospital, Guangzhou, People’s Republic of China; and Marcin Zielinski, Pulmonary Hospital, Zakopane, Poland. Appendix 2
PY - 2013
Y1 - 2013
N2 - The lack of an official-stage classification system for thymic malignancies is an issue that hampers progress in this rare disease. A collaborative effort by the International Association for the Study of Lung Cancer and the International Thymic Malignancies Interest Group is underway to develop proposals for such a system. A database of more than 10,000 cases worldwide has been assembled to provide a solid basis for analysis. This report outlines the structure of the effort and the process that has been designed.
AB - The lack of an official-stage classification system for thymic malignancies is an issue that hampers progress in this rare disease. A collaborative effort by the International Association for the Study of Lung Cancer and the International Thymic Malignancies Interest Group is underway to develop proposals for such a system. A database of more than 10,000 cases worldwide has been assembled to provide a solid basis for analysis. This report outlines the structure of the effort and the process that has been designed.
KW - Staging of stage classification
KW - Thymic carcinoma
KW - Thymoma
UR - http://www.scopus.com/inward/record.url?scp=84892153926&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84892153926&partnerID=8YFLogxK
U2 - 10.1097/JTO.0000000000000017
DO - 10.1097/JTO.0000000000000017
M3 - Article
C2 - 24389429
AN - SCOPUS:84892153926
SN - 1556-0864
VL - 8
SP - 1467
EP - 1473
JO - Journal of Thoracic Oncology
JF - Journal of Thoracic Oncology
IS - 12
ER -